NANicklaus P. Ashburn

Nicklaus P. Ashburn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nicklaus P. Ashburn has a total of 180 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • High-sensitivity HEART Pathway one-and-done troponin strategy is safe and effective

    by Nicklaus P. Ashburn, Anna C. Snavely, Molly R. Ehrig, Aaditya Chandrasekar, Benjamin T. Hutchison, Michael W. Supples, Simon A. Mahler

  • Open Access

    Validation of a 0/2‐Hour Point‐Of‐Care High Sensitivity Troponin Algorithm: A Multisite US Study

    by Simon A. Mahler, Nicklaus P. Ashburn, Akalya Villenthi, David A. Pearson, Hannah D. Pugh, Benjamin T. Hutchison, Michael W. Supples, Anna C. Snavely

    Objectives: A 0/2‐h algorithm for the i‐STAT point‐of‐care (POC) high sensitivity troponin I (hs‐cTnI) assay was recently derived in Australia. The objective of this study was to validate and optimize the performance of the 0/2‐h algorithm in a multisite U.S. Emergency Department (ED) cohort. Methods: A prospective cohort study was conducted at three U.S. EDs (February–September 2025). Adults without STEMI and at least one hs‐cTnI ordered were accrued. Blood samples were collected simultaneously for POC hs‐cTnI measurement on an i‐STAT 1 analyzer (Abbott Laboratories) and central laboratory hs‐cTnI measurement (Beckman Coulter). The primary outcome was index myocardial infarction (MI), adjudicated by experts using clinical hs‐cTnI measures. Diagnostic performance of the Australian 0/2‐h algorithm was assessed by calculating negative and positive predictive values (NPV, PPV) with associated 95% confidence intervals. Efficacy, defined as the proportion of patients classified into the rule‐out zone, was calculated. Algorithm optimization tested modified cut points to increase efficacy while maintaining NPV ≥ 99% and achieving PPV ≥ 65%. Results: During the study period, 578 patients with complete 0/2‐h algorithm assessments were accrued. These patients were 48% (279/578) female, 40% (233/578) non‐White, with a median age of 60 years (IQR: 50–70). Index MI occurred in 7.4% (43/578). Algorithm efficacy was 54.8% (317/578) and 8.8% (51/578) were classified to the rule‐in zone. Among patients ruled‐out, the NPV was 99.4% (95% CI: 97.7%–99.9%). The rule‐in zone was associated with a PPV of 62.7% (95% CI: 48.1%–75.9%). Among 36.3% (210/578) patients classified to the observation zone, 4.3% (9/210) had an adjudicated index MI. An optimized 0/2‐h algorithm increased efficacy to 60.0% (347/578) while achieving an NPV of 99.4% (95% CI: 97.9%–99.9%) and PPV of 74.4% (95% CI: 58.8, 86.5%) for index MI. Conclusions: The original Australian and optimized 0/2‐h algorithms for i‐STAT POC hs‐cTnI measurement had high NPV and efficacy in a multisite U.S. cohort. Trial Registration: Trial Registration: NCT06899776


  • Open Access

    Age Differences in Acute Chest Pain Care in a Multisite US Cohort

    by Nicklaus P. Ashburn, Anna C. Snavely, Lyle Paukner, Michael W. Supples, Benjamin T. Hutchison, David A. Pearson, Simon A. Mahler

    Background: This study aims to determine if differences in age affect safety and healthcare utilization among patients with chest pain in a multisite US ED cohort, after accounting for comorbidities and high‐sensitivity troponin (hs‐cTn). Methods: We conducted a multisite observational study using the Wake Forest Chest Pain Registry, which included patients ≥ 18 years old with chest pain across 25 EDs (01/01/2021 to 12/31/2021). Each site used an hs‐cTn chest pain protocol. Patients were categorized as older (≥ 65 years), middle‐aged (46−64 years), or young (18−45 years). The primary safety outcome was death or MI at 30 days. The primary healthcare utilization outcome was 30‐day hospitalization. Multivariable logistic regression models assessed the association between age and outcomes, adjusting for sex, race, ethnicity, obesity, smoking, rurality, coronary disease, diabetes, hypertension, hyperlipidemia, insurance, site, and hs‐cTn, with young patients as the reference. Results: Among 40 979 patients, 25.1% were older, 39.7% middle‐aged, and 35.2% young. At 30 days, death or MI occurred in 7.3% (750/10 298) of older, 3.8% (611/16 260) of middle‐aged, and 0.8% (108/14 421) of young patients. After adjustment, death or MI at 30 days was more common among older (aOR 1.57, 95% CI 1.17−2.12) and middle‐aged (aOR 1.57, 95% CI 1.22‐2.02) patients. Hospitalization at 30 days occurred in 56.3% (5799/10 298) of older, 35.4% (5761/16 260) of middle‐aged, and 12.8% (1849/14 421) of young patients. With adjustment, hospitalization remained more common among older (aOR 2.51, 95% CI 2.27−2.78) and middle‐aged (aOR 1.93, 95% CI 1.80−2.07) patients. Conclusion: After adjusting for comorbidities and hs‐cTn results, older adults had higher rates of death or MI and hospitalization at 30 days.

  • Single Dose Epinephrine Protocol Is Associated With Improved Survival of Older Adults With Out‐Of‐Hospital Cardiac Arrest

    by Ethan J. Lilien, Nicklaus P. Ashburn, Tyler S. George, Anna C. Snavely, Bryan P. Beaver, Casey G. Costa, Michael A. Chado, Harris A. Cannon, James E. Winslow, R. Darrell Nelson, et al.

    Background: A single‐dose epinephrine protocol (SDEP) for out‐of‐hospital cardiac arrest (OHCA) was recently found to have similar survival to hospital discharge (survival) rates compared to a multidose epinephrine protocol (MDEP). It remains unknown if survival rates vary for SDEP vs. MDEP by age. This study aims to determine if an SDEP protocol improves survival in distinct age groups. Methods: We conducted a pre‐post implementation study (MDEP vs. SDEP) in 5 North Carolina EMS systems from 11/01/2016–10/29/2019 among adult OHCA patients. Demographics and the outcome of survival were sourced from the Cardiac Arrest Registry to Enhance Survival. Patients were categorized as older (≥ 65 years), middle‐aged (46–64 years), and young (18–45 years). Survival rates were compared pre vs. post SDEP implementation within age groups using Generalized Estimating Equations to account for clustering within EMS systems and adjust for sex, race, witnessed arrest, AED application, rhythm type, bystander CPR, arrest location, and EMS response time. The interaction of SDEP implementation with age group was evaluated. Results: Among 1690 patients (899 MDEP, 791 SDEP), 864 were older, 538 were middle‐aged, and 288 were young. Survival occurred in 13.6% (122/899) in the MDEP group and 15.4% (122/791) in the SDEP group. SDEP was associated with improved survival in older patients (12.2% [50/409] vs. 6.6% [30/455]; OR: 1.95, 95% CI 1.58–2.41) and similar survival in middle‐aged (17.5% [47/268] vs. 18.2% [49/270]; OR: 0.96, 95% CI 0.53–1.25) and young (21.9% [25/114] vs. 24.7% [43/174]; OR: 0.88, 95% CI 0.41–1.90) patients. After adjusting, SDEP remained associated with improved survival among older adults (aOR: 1.87, 95% CI 1.36–2.56) and similar survival rates among middle‐aged (aOR: 0.85, 95% CI 0.63–1.15) and young (aOR: 0.82, 95% CI 0.41–1.64) patients. The interactions of SDEP implementation between older and middle‐aged ( p = 0.001) and older and young ( p = 0.05) patients indicate a differential effect. Conclusion: SDEP was associated with improved survival rates among older adults.


  • Open Access

    Does Single Dose Epinephrine Improve Outcomes for Patients with Out-of-Hospital Cardiac Arrest by Sex or Race?

    by Breanna L. Blaschke, Nicklaus P. Ashburn, Anna C. Snavely, Kristina Dev, Tyler S. George, Bryan P. Beaver, Michael A. Chado, Harris A. Cannon, James E. Winslow, R. Darrell Nelson, et al.

    Introduction: Recent evidence suggests that survival to hospital discharge in patients with out-of-hospital cardiac arrest (OHCA) is similar among patients receiving a single dose epinephrine protocol compared to a multi-dose epinephrine protocol. However, it is unknown whether survival to hospital rates differ for single dose vs. multi-dose epinephrine within sex and race subgroups. Our objective in this study was to determine whether survival to hospital discharge rates varied for single dose vs. multi-dose epinephine protocols among men, women, White, and non-White patients. Methods: We conducted a pre-post Single Dose Epinephrine Implementation Study from November 1,2016 – October 29, 2019 at five North Carolina emergency medical services (EMS) systems, involving patients ≥ 18 years old with non-traumatic OHCA. Data on race, sex, and the primary outcome of survival to hospital discharge were determined from the Cardiac Arrest Registry to Enhance Survival and from EMS records. We performed intention-to-treat analysis. We compared survival to hospital discharge rates between single dose vs multi-dose epinephrine protocols within sex and race subgroups using generalized estimating equations with a logit link to account for clustering among EMS agencies and to adjust for age, witnessed arrest, automated external defibrillator availability, EMS response interval, the presence of a shockable rhythm, receiving bystander cardiopulmonary resuscitation, and sex or race. In the model, we evaluated interactions between epinephrine protocol and race and sex. Results: Of the 1,690 patients included, (899 multi-dose, 791 single dose), 38.7% (657/1,690) were female and 74.7% (1,262/1,690) were White. Survival to hospital discharge occurred in 13.6% (122/899) of patients in the multi-dose group and 15.4% (122/791) in the single dose epinephrine group (OR 1.19, 95%CI 0.89-1.59). Single dose epinephrine was associated with increased survival to hospital discharge rates in White patients (adjusted odds ratio [aOR] 1.17, 95% confidence interval [CI] 1.05-1.30). However, the rates were similar for single dose vs. multi-dose epinephrine among men (aOR 1.03, 95% CI 0.93-1.14), women (aOR 1.23, 95% CI 0.97-1.56), and non-White patients (aOR 1.08, 95% CI 0.78-1.51). Interactions between epinephrine protocol and subgroups were not significant. Conclusion: Rates of survival to hospital discharge were similar in the single dose and multi-dose epinephrine strategies regardless of sex. Single dose epinephrine was associated with increased survival to hospital discharge among White patients but not in non-White patients, which may be due to unmeasured confounding or inadequate power.

  • Open Access

    Untreated Hypertension and Diabetes in the Chest Pain Observation Unit

    by Benjamin T. Hutchison, Nicklaus P. Ashburn, Anna C. Snavely, Michael D. Shapiro, Michael A. Chado, Alexander P. Ambrosini, Amir A. Biglari, Harris A. Cannon, Marissa J. Millard, Alexa G. Dameron, et al.

    Introduction: Hypertension and diabetes are common cardiovascular disease risk factors among emergency department observation unit (EDOU) patients evaluated for acute coronary syndrome (ACS). Our primary aim was to determine rates of untreated hypertension and diabetes in the EDOU. Our secondary aim was to identify rates of glycemic control assessment among patients with diabetes. Methods: We conducted a retrospective, observational cohort study of patients ≥ 18 years old evaluated for ACS in a tertiary care center EDOU from March 3, 2019–February 28, 2020. Known diagnoses prior to EDOU encounter and new outpatient diagnoses within one year for hypertension and diabetes were identified by health record data. We defined untreated hypertension and diabetes as no antihypertensive or antihyperglycemic prescriptions or diabetes counseling within one year. We calculated treatment rates with exact 95% confidence intervals (CI). Multivariable logistic regression adjusting for age, sex, and race compared treatment rates among men vs women and White vs non-White patients. Rates of glycemic control assessment were defined by the proportion of patients with known diabetes who received hemoglobin A1c (HbA1c) measurement within one year. Results: Among 649 EDOU patients, 59.5% (386/649) were female and 43.8% (284/649) were non?White with a mean age of 59 ± 12 years. Of these, 76.9%(499/649) had known hypertension and 31.3% (203/649) had known diabetes. Within one year, 3.1% (20/649) had newly diagnosed hypertension and 3.2% (21/649) had newly diagnosed diabetes. Among those with known or newly diagnosed hypertension, untreated hypertension occurred in 36.4% (189/519; 95% CI 32.3 - 40.7). Hypertension treatment rates were similar in men vs women (aOR [adjusted odds ratio] 0.82, 95% CI 0.57 - 1.19) and White vs non?White patients (aOR 0.95, 95% CI 0.66 - 1.38). Among those with known or newly diagnosed diabetes, untreated diabetes occurred in 25.0% (56/224; 95% CI 18.5 - 31.2). Diabetes treatment rates were similar in men vs women (aOR 1.41, 95% CI 0.72 - 2.74) and White vs. non-White patients (aOR 1.05, 95% CI 0.56 - 1.97). At one year, just 32.0% (65/203) of patients with diabetes had HbA1c testing. Conclusion: Given that many patients evaluated for acute coronary syndrome in the ED observation unit do not receive treatment for hypertension and diabetes within one year of presentation, clinicians should consider initiating EDOU-based preventive cardiovascular care for these conditions.


  • Open Access

    Mixed-Methods Investigation of Rural Emergency Medical Services ST-Elevation Myocardial Infarction Time to Percutaneous Coronary Intervention: High- vs Low-Performing Agencies

    by Michael Supples, McKenna E. Gallagher, Nicklaus P. Ashburn, Anna C. Snavely, Ashley E. Strahley, Chadwick D. Miller, Simon A. Mahler, Jason P. Stopyra

    Background: Patients with ST-elevation myocardial infarction (STEMI) cared for by rural emergency medical services (EMS) agencies commonly do not have first medical contact-to-percutaneous coronary intervention (PCI) time within the recommended goal of 90 minutes. In this study we identify factors associated with performance variation among rural EMS agencies in first medical contact-to-PCI time. Methods: In this explanatory, sequential, mixed-methods study, we ranked eight rural county EMS agencies by continuous first medical contact-to-PCI time, accounting for loaded mileage, using data from a regional STEMI registry (2016–2019). A qualitative researcher conducted 28, one-hour, semi-structured interviews from January– March 2021 with the EMS director, training officer, medical director, and four paramedics at the top two high- and bottom two low-performing rural EMS agencies. Key informants were blinded to agency STEMI performance. Interviews were structured to identify positive deviance by exploring agencies’ clinical approach to patients with chest pain, their organizational culture, structure, and quality improvement (QI) activities regarding STEMI care, and recommendations for improving STEMI performance. Interviews were digitally recorded and transcribed verbatim by a professional transcription service. We established a codebook and performed a thematic analysis using an inductive approach. We summarized and compared data across agencies to identify commonalities and differences between high- and low-performing agencies. Findings were reviewed and validated by an expert panel. Results: The top two highest-performing EMS agencies had a median first medical contact-to-PCI time of 79 minutes (interquartile range [IQR] 65-91) minutes vs 98 minutes (IQR 82-120) among the bottom two lowest-performing agencies, P<.001. Both high- and low-performing agencies identified issues with electrocardiogram (ECG) transmitting technology and cumbersome hospital activation communications. However, top-performing agencies shared a culture that encourages early EMS activation of the cardiac catheterization lab after STEMI recognition. Top-performing agencies also placed a higher value on QI and training. These agencies prioritized mission and chain of command over staff relationships/interpersonal bonds; have stable, strong leadership; provide opportunities for career advancement; and collaborate with community leaders. Conclusion: Top-performing rural EMS agencies for STEMI care promote early activation, have a strong chain of command, are mission focused, and have a greater focus on quality improvement and training.


  • Open Access

    Multisite Validation of a Strategy to Identify Very Low Risk Emergency Department Patients Without Troponin

    by Nicklaus P. Ashburn, Anna C. Snavely, Akalya Villenthi, Tara Hashemian, Michael W. Supples, Simon A. Mahler


  • Initiating Preventive Care for Hyperlipidemia in the Emergency Department: The Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

    by Nicklaus P. Ashburn, Anna C. Snavely, Molly R. Mb Ehrig, Michael D. Do Shapiro, David M. Md Herrington, David M. Reboussin, Sabina B. Gesell, Simon A. Mahler

    Background: Hyperlipidemia (HLD) is a major contributor to atherosclerotic cardiovascular disease (ASCVD). Nearly 30% of emergency department (ED) patients with chest pain have undiagnosed and/or unmanaged HLD, putting them at an increased risk of ASCVD. Although safe and effective HLD treatments exist, the ED traditionally focuses on acute care and does not offer preventive cardiovascular care services. This represents a large, missed opportunity to improve cardiovascular health for the millions of Americans evaluated in the ED each year who are not receiving appropriate preventive care in the outpatient setting. The goals of this study are to determine the efficacy of novel ED-initiated preventive care on lowering cholesterol while also informing our understanding of patient adherence and implementation determinants of ED-initiated preventive cardiovascular care. Methods: We will use a randomized, controlled, parallel-group trial of 130 ED patients being evaluated for acute coronary syndrome at a single site. Participants will be 40–75 years old with prior ASCVD, known diabetes, or 10-year ASCVD risk ≥7.5% who are not already receiving guideline-directed outpatient preventive care. Patients will be randomized with equal probability to EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders) or usual care. Patients in the EMERALD arm will be started on a statin and referred for a 30-day follow-up with cardiology or primary care, depending on the 10-year ASCVD risk level. Usual care arm patients will not be prescribed a statin in the ED and will be asked to follow up with a primary care provider. The primary outcome will be a percent change in low-density lipoprotein cholesterol at 30 days. Secondary outcomes include percent change in low-density lipoprotein cholesterol at 180 days and nonhigh-density lipoprotein cholesterol at 30- and 180 days, the proportion of EMERALD patients who pick up their statin, and the proportion of patients who attend 30-day outpatient follow-up. We will also use mixed methods and semistructured interviews to identify patient adherence facilitators and barriers and implementation determinants for Emergency Medicine providers. Discussion: This is the first study to evaluate a novel, protocolized ED-initiated preventive cardiovascular care approach for HLD. If successful, the EMERALD intervention may be able to improve the cardiovascular health for at-risk patients and serve as a use case for other modifiable cardiovascular disease risk factors, such as diabetes, hypertension, tobacco use, and obesity. This single-site study will inform a planned multisite trial.


  • Open Access

    Feasibility and efficacy of simulation training for joint dislocation management in residency

    by Cedric W. Lefebvre, Nicholas D. Hartman, Casey Glass, Eric Daubach, Tewodros Wodajo, Benjamin Hutchison, Thea Lance, Nicole J. Prendergast, Nicklaus P. Ashburn